<DOC>
	<DOC>NCT02314754</DOC>
	<brief_summary>To demonstrate non-inferiority of the efficacy of 200 mg mifepristone followed in 24 to 48 hours by 800 Âµg buccal misoprostol in outpatient medical abortion services among women 71-77 days' compared to women 64-70 days' LMP.</brief_summary>
	<brief_title>Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>intrauterine pregnancy between 64 days and 77 days' LMP eligible for medical abortion according to study doctor assessment willing and able to sign consent form speak english or spanish (in US sites); speak the local language(s) (in international sites) agree to comply with the study procedures and visit schedule Have known allergies or present other contraindications to mifepristone or misoprostol</criteria>
	<gender>Female</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>